Back to JPMorgan Chase & Co. JPMorgan Chase & Co.

GILD

8 quarters

Position history for JPMorgan Chase & Co.JPMorgan Chase & Co.'s holdings in Gilead Sciences, Inc.

Yes. JPMorgan Chase holds 20,820,621 shares of GILD (Gilead Sciences), worth $2.6B, as of its Q2 2026 13F filing. It reduced the position by 13,171,789 shares (-38.8%) from Q1 2026. JPMorgan Chase has held GILD in every 13F on record since Q3 2024, 8 quarterly filings. GILD is 0.1% of JPMorgan Chase's reported 13F portfolio.

Current Value

$2.6B

Current Shares

20.8M

Total Value Change

+$2.1B

Total Shares Change

+14.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
20.8M
-38.8%
$2.6B0.1%$125.63
0
2026-Q1
Increased
34M
+47.6%
$4.6B0.3%$137.68
52
2025-Q4
Increased
23M
+8.8%
$2.8B0.2%$120.57
42
2025-Q3
Increased
21.2M
+10.9%
$2.3B0.1%$108.32
42
2025-Q2
Increased
19.1M
+72.2%
$2.1B0.1%$107.45
57
2025-Q1
Increased
11.1M
+97.5%
$1.2B0.1%$107.83
51
2024-Q4
Decreased
5.6M
-15.8%
$518.1M0.0%$88.27
0
2024-Q3
First report
6.7M
-
$558.7M0.0%$79.45
0

Other major holders of GILD: BlackRock, Inc., Vanguard Group Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used